Orchestra BioMed
OBIO
OBIO
22 hedge funds and large institutions have $193M invested in Orchestra BioMed in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$80.6M | |
| 2 | +$44.6M | |
| 3 | +$2.49M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.04M |
Top Sellers
| 1 | -$6.09M | |
| 2 | -$3.99M | |
| 3 | -$3.99M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$3.92M |
| 5 |
SCM
Sio Capital Management
New York
|
-$2.5M |